Skip to content

Viatris Inc (VTRS) stock: revenue, earnings & dividend

Viatris Inc (VTRS, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener VTRS · Nasdaq Pharma & Biotech US-PA

Key figures

Fiscal year
2025
Revenue
14.3 bn $
Revenue growth
-3 %
Revenue growth 5y (p.a.)
3.7 %
Net income
–
Net margin
–
Operating margin
-18.6 %
Earnings per share (diluted)
-3.00 $
Dividend per share
0.48 $
Payout ratio
–
Consecutive dividend years
5 years
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
37.2 bn $
Equity
14.7 bn $
Equity ratio
39.6 %
Return on equity
–
Cash
1.32 bn $
Operating cash flow
2.32 bn $
Free cash flow
1.94 bn $
Shares outstanding
1,146,454,729

History

Revenue by fiscal year

2018 11.4 bn $
2019 11.5 bn $
2020 11.9 bn $
2021 17.9 bn $
2022 16.3 bn $
2023 15.4 bn $
2024 14.7 bn $
2025 14.3 bn $

Net income by fiscal year

2019 0 $

Dividend per share

2021 0.33 $
2022 0.48 $
2023 0.48 $
2024 0.48 $
2025 0.48 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202514.3 bn $–-3.00 $0.48 $2.32 bn $
202414.7 bn $–-0.53 $0.48 $2.3 bn $
202315.4 bn $–0.05 $0.48 $2.9 bn $
202216.3 bn $–1.71 $0.48 $3 bn $
202117.9 bn $–-1.05 $0.33 $3.02 bn $
202011.9 bn $–-1.11 $–1.23 bn $
201911.5 bn $0 $0.03 $–1.8 bn $
201811.4 bn $–0.68 $–2.34 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)